Paper657268
Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.
Clemens MJ and 1 other. Cell, 1978. Cited by 382 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Papers, record 657268. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/657268
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Oligonucleotides | Major topic |
| Protein Biosynthesis | Major topic |
| Cell-Free System | |
| Emetine | |
| L Cells | |
| Peptide Chain Initiation, Translational | |
| Polyribosomes | |
| RNA, Messenger | |
| RNA, Transfer |
Source PubMed
Cited by138
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 382 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42190814 | SARS-CoV-2 5'-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1). | J Biol Chem | 2026 | https://conductscience.org/library/papers/42190814 | PubMed |
| 41959085 | SARS-CoV-2 5'-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1). | bioRxiv | 2026 | https://conductscience.org/library/papers/41959085 | PubMed |
| 41758647 | RNase L regulates the antiviral proteome by accelerating mRNA decay, inhibiting nuclear mRNA export, and repressing transcription. | Cell Rep | 2026 | https://conductscience.org/library/papers/41758647 | PubMed |
| 41618367 | PRRSV Nsp11 antagonizes host antiviral immune response by reducing OAS1 and RNase L expressions. | BMC Vet Res | 2026 | https://conductscience.org/library/papers/41618367 | PubMed |
| 41445750 | Acid ceramidase regulates CD8+ T-cell exhaustion via type I interferon-mediated upregulation of PD-L1. | Front Immunol | 2025 | https://conductscience.org/library/papers/41445750 | PubMed |
| 40730656 | Manipulation of the nucleotide pool in human, bacterial and plant immunity. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/40730656 | PubMed |
| 40588419 | Condensation of human OAS proteins initiates diverse antiviral activities in response to West Nile virus. | Genes Dev | 2025 | https://conductscience.org/library/papers/40588419 | PubMed |
| 39779213 | RNA sensing at the crossroads of autoimmunity and autoinflammation. | RNA | 2025 | https://conductscience.org/library/papers/39779213 | PubMed |
| 38551960 | Initiation of a ZAKα-dependent ribotoxic stress response by the innate immunity endoribonuclease RNase L. | Cell Rep | 2024 | https://conductscience.org/library/papers/38551960 | PubMed |
| 38443657 | Crosstalk between vault RNAs and innate immunity. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38443657 | PubMed |
| 38018976 | Zika virus infection triggers caspase cleavage of STAT1. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38018976 | PubMed |
| 37876532 | Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice. | Mol Ther Nucleic Acids | 2023 | https://conductscience.org/library/papers/37876532 | PubMed |
| 37751211 | The Many Faces of Oligoadenylate Synthetases. | J Interferon Cytokine Res | 2023 | https://conductscience.org/library/papers/37751211 | PubMed |
| 37745867 | Association of IFNAR2 rs2236757 and OAS3 rs10735079 Polymorphisms with Susceptibility to COVID-19 Infection and Severity in Palestine. | Interdiscip Perspect Infect Dis | 2023 | https://conductscience.org/library/papers/37745867 | PubMed |
| 36939319 | 2-5A-Mediated decay (2-5AMD): from antiviral defense to control of host RNA. | Crit Rev Biochem Mol Biol | 2022 | https://conductscience.org/library/papers/36939319 | PubMed |
| 36227523 | The Influenza-Induced Pulmonary Inflammatory Exudate in Susceptible Tpl2-Deficient Mice Is Dictated by Type I IFN Signaling. | Inflammation | 2023 | https://conductscience.org/library/papers/36227523 | PubMed |
| 35603217 | Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases. | Front Immunol | 2022 | https://conductscience.org/library/papers/35603217 | PubMed |
| 34938858 | Improved lentiviral vector titers from a multi-gene knockout packaging line. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/34938858 | PubMed |
| 34835115 | How Influenza A Virus NS1 Deals with the Ubiquitin System to Evade Innate Immunity. | Viruses | 2021 | https://conductscience.org/library/papers/34835115 | PubMed |
| 34372695 | Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity. | mBio | 2021 | https://conductscience.org/library/papers/34372695 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/657268
GET https://conductscience.org/api/papers/v1/657268/cited_by?page=2